DOES THE 'QUEEN OF SPICES' LIVE UP TO ITS NAME? THE THERAPEUTIC POTENTIAL OF ELETTARIA CARDAMOMUM: A NARRATIVE REVIEW OF CURRENT EVIDENCE AND MOLECULAR MECHANISMS
Authors:
- Weronika PraskaWPWeronika Praska
- Dominika GalińskaDGDominika Galińska
- Natalia DomańskaNatalia Domańska
- Anna RomanARAnna Roman
- Joanna ZajączkowskaJZJoanna Zajączkowska
- Natalia MarzecNMNatalia Marzec
- Natalia KrupaNKNatalia Krupa
- Aleksandra MarzecAMAleksandra Marzec
- Małgorzata CherekMCMałgorzata Cherek
- Stanisław Maria WardęCkiSWStanisław Maria WardęCki
Open Access
- 7 September 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Abstract
Background: Green cardamom is the dried fruit of the herbaceous plant Elettaria cardamomum, originating from India. Due to its rich heritage in Ayurvedic medicine, mostly as a respiratory and digestive aid, as well as its distinct flavour, it has been historically known as the „Queen of Spices”. Despite its comprehensive pharmacological profile, green cardamom is frequently overshadowed by other functional spices, such as turmeric or cinnamon. Purpose: This narrative review aims to evaluate current evidence on green cardamom’s clinical therapeutic efficacy, with emphasis on metabolic, cardiovascular and gastrointestinal health, as well as potential anti-cancer and neuroprotective properties. Methods: A comprehensive review of literature was performed, using databases such as PubMed and Google Scholar. Relevant articles were found, including human clinical trials, animal models, in vitro studies, meta-analyses and systematic reviews. Results: Current evidence suggests that green cardamom’s therapeutic effects are primarily mediated through antioxidant and anti-inflammatory pathways. In metabolic and cardiovascular contexts, cardamom consistently improves insulin resistance, endothelial function, triglyceride levels and provides cardioprotection during ischemic events. However, human clinical data regarding its effects on obesity indexes and total cholesterol remain inconsistent. Gastrointestinally, the spice acts as both a spasmogenic and spasmolytic agent and offers protection against gastric ulcers. Oncological research highlights cardamom’s selective cytotoxicity, particularly against triple-negative breast cancer. In in vitro and animal models, the spice has shown promising results in management of Alzheimer’s disease and anxiety. Furthermore, its essential oil exhibits broad-spectrum antimicrobial activity.Keywords
This publication has 53 references indexed in Scilit:
- Preliminary Assessment of Essential and Potentially Toxic Elements in the Most Common Spices in a Developing Country: Health Hazard ImplicationBiological Trace Element Research, 2025
- Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trialEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2021
- Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer’s Disease than 1,8-Cineole Alone?NeuroMolecular Medicine, 2019
- Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double‐blind placebo controlled clinical trialJournal of the Science of Food and Agriculture, 2019
- Terpenoid-rich Elettaria cardamomum extract prevents Alzheimer-like alterations induced in diabetic rats via inhibition of GSK3β activity, oxidative stress and pro-inflammatory cytokinesCytokine, 2019
- Cardamom supplementation improves inflammatory and oxidative stress biomarkers in hyperlipidemic, overweight, and obese pre‐diabetic women: a randomized double‐blind clinical trialJournal of the Science of Food and Agriculture, 2017
- The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorderBiomedicine & Pharmacotherapy, 2017
- Anti‐hypercholesterolemic influence of the spice cardamom (Elettaria cardamomum) in experimental ratsJournal of the Science of Food and Agriculture, 2017
- Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β‐catenin signaling cascades and reversal of epithelial–mesenchymal transitionBioFactors, 2016
- Cardamom extract as inhibitor of human platelet aggregationPhytotherapy Research, 2005